Publications

<< back

• Dr Phyllis Spuls
  
  2013
  Spuls PhI, Scholten RJPM. Weinig bewezen effectieve behandelopties voor chronische blefaritis. NTVG 2013;157:39.
  
  de Vries ACQ, Bogaards NA, Hooft L, Velema M, Pasch M, Lebwohl M, Spuls PI. Interventions for nail psoriasis. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD007633. DOI: 10.1002/14651858.CD007633.pub2.
  
  2012
  
  Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy. 2012 Jan;67(1):99-106.
  
  Spuls PhI, Go P. Endoveneuze ablatie en sclerotherapie versus conventionele chirurgie bij stamvarices. Ned Tijdschr Geneeskd 2012;156:A4476 (In het kort)
  van Cranenburgh OD, Prinsen CA, Sprangers MA, Spuls PI, de Korte J. Health-related quality-of-life assessment in dermatologic practice: relevance and application. Dermatol Clin. 2012;30(2):323-32.
  
  Spuls PhI, de Bes J. Psoriasis. In: van Everdingen JJE, Bik CMJM. Samenvatting Richtlijnen Dermatologie 2012, tweede druk: 145-159.
  Spuls PhI, Bes J. Psoriasis. In: van Everdingen JJE, Bik CMJM. Richtlijn Psoriasis 2012.
  
  Van der Schroeff JG, Spuls PhI. Richtlijn off-label geneesmiddelengebruik in de dermatologie. Ned Tijd Dermatol Venereol 2012;22:174-175.
  
  Schram ME, Roekevisch E, Leeflang MM, Bos JD, Schmitt J, Spuls PI.
  Response to a randomized trial of methotrexate vs. azathioprine for severe atopic eczema: a critical appraisal. Br J Dermatol. 2012;166(4):704. (see Patel AN et al)
  Ormerod AD, Augustin M, Baker C, Chosidow O, Cohen AD, Dam TN, Garcia-Doval I, Lecluse LL, Schmitt-Egenolf M, Spuls PI, Watson KD, Naldi L. Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies. Dermatology. 2012 2012;224(3):236-43.
  
  Jochen Schmitt, Phyllis Spuls, Maarten Boers, Kim Thomas, Joanne Chalmers, Evelien Roekevisch, Mandy Schram, Richard Allsopp, Valeria Aoki, Christian Apfelbacher, Carla Bruijnzeel-Koomen, Marjolein Bruin-Weller, Carolyn Charman, Arnon Cohen, Magdalene Dohil, Carsten Flohr, Masutaka Furue, Uwe Gieler, Lotty Hooft, Rosemary Humphreys, Henrique Akira Ishii, Ichiro Katayama, Willem Kouwenhoven, Sinéad Langan, Sue Lewis-Jones, Stephanie Merhand, Hiroyuki Murota, Dedee F. Murrell, Helen Nankervis, Yukihiro Ohya, Arnold Oranje, Hiromi Otsuka, Carle Paul, Yael Rosenbluth, Hidehisa Saeki, Marie-Louise Schuttelaar, Jean-Francois Stalder, Åke Svensson, Roberto Takaoka, Carl-Fredrik Wahlgren, Stephan Weidinger, Andreas Wollenberg , Hywel Williams. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Core outcome measures for atopic eczema research. Allergy 2012;67(9):1111-7
  
  Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, Trakatelli M, Finner A, Kiesewetter F, Trüeb R, Rzany B, Blume-Peytavi U; European Dermatology Forum (EDF). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011 Oct;9 Suppl 6:S1-57.
  
  Linthorst Homan MW, Spuls PI, Nieuweboer-Krobotova L, de Korte J, Sprangers MA, Bos JD, Wolkerstorfer A, van der Veen JP. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. J Eur Acad Dermatol Venereol. 2012 Jun;26(6):690-5.
  
  Vrijman C, Kroon MW, Limpens J, Leeflang MM, Luiten RM, van der Veen JP, Wolkerstorfer A, Spuls PI. The prevalence of thyroid disease in vitiligo patients: a systematic review. Br J Dermatol. 2012;167(6):1224-35.
  
  Vrijman C, Homan ML, Limpens J, van der Veen W, Wolkerstorfer A, Terwee CB, Spuls PI. Measurement Properties of Outcome Measures for Vitiligo: A Systematic Review. Arch Dermatol. 2012 Sep 17
  
  Spuls PI, Hooft L. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal: ORIGINAL ARTICLE: Papp KA, Leonardi C, Menter A et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012; 366: 1181-9.ORIGINAL ARTICLE: Leonardi C, Matheson R, Zachariae C, et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 2012; 366: 1190-9. Br J Dermatol. 2012 Oct;167(4):710-3.
  
  Prinsen CA, Spuls PI, Sprangers MA, de Rie MA, Legierse CM, de Korte J. The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: study protocol for a multicenter randomized controlled trial. Trials. 2012 Dec 8;13(1):236. [Epub ahead of print]
  
  2011
  
  Lecluse LL, Dowlatshahi EA, Limpens CE, de Rie MA, Bos JD, Spuls PI. Etanercept: an overview of dermatologic adverse events. Arch Dermatol. 2011 Jan;147(1):79-94.
  
  van der Heijden JP, de Keizer NF, Bos JD, Spuls PI, Witkamp L. Teledermatology applied following patient selection by general practitioner in daily practice improves efficiency and quality of care at lower costs. Br J Dermatol. 2011 Jul 5. doi: 10.1111/j.1365-2133.2011.10509.x. [Epub ahead of print]
  
  Linthorst Homan MW, Spuls PI, Nieuweboer-Krobotova L, de Korte J, Sprangers MA, Bos JD, Wolkerstorfer A, van der Veen JP. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. J Eur Acad Dermatol Venereol. 2011 Jun 29. doi: 10.1111/j.1468-3083.2011.04147.x. [Epub ahead of print]
  
  Vrijman C, van Drooge AM, Limpens CE, Bos JD, van der Veen JP, Spuls PI, Wolkerstorfer A. Laser and intense pulsed light therapy for the treatment of hypertrophic scars: a systematic review. Br J Dermatol. 2011 Jun 28. doi: 10.1111/j.1365-2133.2011.10492.x. [Epub ahead of print]
  
  Spuls PI, Nijsten T. Survival in cancer patients hospitalized for psoriasis: a commentary. Br J Dermatol. 2011 Jul;165(1):1-2. doi: 10.1111/j.1365-2133.2011.10442.x. No abstract available.
  
  Borgonjen RJ, van Everdingen JJ, Bik CM, Tuut MK, Spuls PI, van de Kerkhof PC. Prospective comparison of three guideline development methods for treatment of actinic keratosis. BMJ Qual Saf. 2011 May 26. [Epub ahead of print]
  
  Schram ME, Roekevisch E, Leeflang MM, Bos JD, Schmitt J, Spuls PI. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol. 2011: Apr 21 [Epub ahead of print]
  …
  Schram ME, Borgonjen RJ, Bik CM, van der Schroeff JG, van Everdingen JJ, Spuls PI; Off-Label Working and Project Group of Dutch Society of Dermatology and Venereology.. Off-label use of azathioprine in dermatology: a systematic review. Arch Dermatol. 2011 Apr;147(4):474-88. Review.
  
  Schram ME, Leeflang MM, DEN Ottolander JP, Spuls PI, Bos JD. Validation and refinement of the Millennium Criteria for atopic dermatitis. J Dermatol. 2011 Mar 31. doi: 10.1111/j.1346-8138.2011.01202.x. [Epub ahead of print]
  
  Kramer SF, Spuls PI. Niet-hormonale behandeling van opvliegers na behandelde borstkanker. NTVG 2011;155(17):A3251.
  
  Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, Trakatelli M, Finner A, Kiesewetter F, Trüeb R, Rzany B, Blume-Peytavi U; European Dermatology Forum (EDF). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011 Oct;9 Suppl 6:S1-57.
  
  van der Heijden JP, de Keizer NF, Bos JD, Spuls PI, Witkamp L. Teledermatology applied following patient selection by general practitioners in daily practice improves efficiency and quality of care at lower cost. Br J Dermatol 2011 Nov;165(5):1058-65.
  
  Vrijman C, van Drooge AM, Limpens J, Bos JD, van der Veen JP, Spuls PI, Wolkerstorfer A. Laser and intense pulsed light therapy for the treatment of hypertrophic scars: a systematic review. Br J Dermatol 2011 Nov;165(5):934-42.
  
  Spuls PhI, Nijsten TEC. Chapter 9. Systematic reviews and meta-analyses. In: Maibach H, Gorouchi F. Evidence Based Dermatology, second edition, 2011:111-124. ISBN-13:978-1-60795-039-4.
  
  Bik CMJM, Spuls PhI, Nijsten TEC. Het off-label gebruik van biologicals in de dagelijkse dermatologische praktijk. Rapport Regieraad Kwaliteit van Zorg, 2011, project nummer: 89-89100-98-207.
  
  Jochen Schmitt, Phyllis Spuls, Hywel Williams. The Harmonizing outcome measures for Eczema (HOME) initiative Plos One 28 Jun 2011
  
  2010
  
  Spuls PI, Lecluse LL, Poulsen ML, Bos JD, Stern RS, Nijsten T. How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review. J Invest Dermatol. 2010; april 130(4):933-43.
  
  Bos JD, Brenninkmeijer EE, Schram ME, Middelkamp-Hup MA, Spuls PI, Smitt JH. Atopic eczema or atopiform dermatitis. Exp Dermatol. 2010 Apr;19(4):325-31. Epub 2010 Jan 22.
  
  Lecluse LL, Driessen RJ, Spuls PI, de Jong EM, Stapel SO, van Doorn MB, Bos JD, Wolbink GJ. Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis. Arch Dermatol. 2010 Feb;146(2):127-32.
  
  Pathirana D, Nast A, Ormerod AD, Reytan N, Saiag P, Smith CH, Spuls P, Rzany B. On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: structure and challenges. J Eur Acad Dermatol Venereol. 2010;24(12):1458-1467
  
  Schram ME, Tedja AM, Spijker R, Bos JD, Williams HC, Spuls PI. Is there a rural/urban gradient in the prevalence of eczema? A systematic review. Br J Dermatol. 2010;162(5):964-73.
  
  van der Heijden JP, Spuls PI, Voorbraak FP, de Keizer NF, Witkamp L, Bos JD. Tertiary teledermatology: a systematic review. Telemed J E Health. 2010;16(1):56-62.
  
  Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Daudén E, Gisondi P, Iversen L, Kemény L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res. 2010 Jan;303(1):1-10. Epub Sep 21.
  
  Van Lümig PP, Lecluse LL, Driessen RJ, Spuls PI, Boezeman JB, Van De Kerkhof PC, De Jong EM. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept. Br J Dermatol. 2010;163(4):838-46.
  
  Brenninkmeijer EE, Spuls PI, Lindeboom R, Van Der Wal AC, Bos JD, Wolkerstorfer A. Excimer laser vs. clobetasol propionate 0•05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot. Br J Dermatol. 2010;163(4):823-31.
  
  Spuls PH, van Leent EJM. Effectiviteit van antimicrobiële therapie bij niet-zwangeren met bacteriële vaginose. Ned Tijdschr Geneeskd. 2010;154:A1592. (In het kort)
  
  Spuls PI, Nast A. Evaluation of and perspectives on guidelines: what is important? J Invest Dermatol. 2010;130(10):2348-9.
  
  van der Heijden JP, de Keizer NF, Voorbraak FP, Witkamp L, Bos JD, Spuls PI. A pilot study on tertiary teledermatology: feasibility and acceptance of telecommunication among dermatologists. J Telemed Telecare. 2010;16(8):447-53. Epub 2010 Oct 4.
  
  Schmitt J, Williams H; HOME Development Group. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol. 2010 Dec;163(6):1166-8.
  
  2009
  
  Spuls PI et al. Cochrane protocol: Interventions for nail psoriasis. Issue I 2009.
  
  Lecluse LL, de Groot M, Bos JD, Spuls PI. Experience with biologics for psoriasis in daily practice: switching is worth a try. Br J Dermatol. 2009 Aug 7 [Epub ahead of print]
  
  Linthorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, Wietze van der Veen JP. The burden of vitiligo: Patient characteristics associated with quality of life. J Am Acad Dermatol. 2009 Jul 2. [Epub ahead of print]
  
  Lecluse LL, Tutein Nolthenius JL, Bos JD, Spuls PI. Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored. Br J Dermatol. 2009 Jun;160(6):1340-3. Epub 2009 Apr 9.
  
  Nast A, Spuls PH, Ormerod AD, Reytan N, Saiag PH, Smith CH, Rzany B. A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines. J Eur Acad Dermatol Venereol. 2009 Jul;23(7):782-7. Epub 2009 Feb 28.
  
  Lecluse LL, Naldi L, Stern RS, Spuls PI. National registries of systemic treatment for psoriasis and the European 'Psonet' initiative. Dermatology. 2009;218(4):347-56. Epub 2008 Dec 11.
  
  Pathirana D., Ormerod A. D., Saiag P., Smith C., Spuls P. I., Nast A., Barker J., Bos J. D., Burmester G.-R., Chimenti S., Dubertret L., Eberlein B., Erdmann R., Ferguson J., Girolomoni G., Gisondi P., Giunta A., Griffiths C., Hönigsmann H., Hussain M., Jobling R., Karvonen S.-L., Kemeny L., Kopp I., Leonardi C., Maccarone M., Menter A., Mrowietz U., Naldi L., Nijsten T., Ortonne J.-P., Orzechowski H.-D., Rantanen T., Reich K., Reytan N., Richards H., Thio H. B., van de Kerkhof P., Rzany B.: European S3-guidelines on the systemic treatment of psoriasis vulgaris. in: J Eur Acad Dermatol 2009;23:1 – 70.
  
  Spuls PH, Nijsten T. Zalven en smeren is effectief in de behandeling van psoriasis. Ned Tijdschr Geneeskd. 2009;153:A842. (In het kort)
  
  Spuls PH, Offringa M. Magnesiumsulfaat bij dreigende vroeggeboorte: minder risico op spasticiteit bij baby’s. Ned Tijdschr Geneeskd. 2009;153:A558. (In het kort)
  
  Spuls PH, Opstelten W. Effectiviteit antibiotica bij mastitis puerperalis niet bewezen. Ned Tijdschr Geneeskd. 2009;153:A513. (In het kort)
  
  2008
  
  Brenninkmeijer E. E. A., Schram M. E., Leeflang M. M. G., Bos J. D., Spuls Ph I.: Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 2008;158(4):754-65.
  
  Brenninkmeijer Elian E. A., Spuls Phyllis I., Legierse Catharina M., Lindeboom Robert, Smitt J. Henk Sillevis, Bos Jan D.: Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol 2008;58(3):407-14.
  
  Bos JD, Spuls PI.Topical treatments in psoriasis: today and tomorrow. Clin Dermatol. 2008 Sep-Oct;26(5):432-7.
  
  Wakkee M, Lugtenberg M, de Jong E, Spuls Ph, Thio B, Westert G, Nijsten T. Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe psoriasis among Dutch dermatologists. Br J Dermatol 2008; 159(2):426-32.
  
  Nijsten T, Spuls Ph, Stern R. STROBE: a beacon for observational studies. Archives of Dermatol 2008;144(9):1200-4.
  
  Wakkee M, Thio HB, Spuls PI, de Jong EM, Nijsten T. Evaluation of the reimbursement criteria for biological therapies for psoriasis in the Netherlands. Br J Dermatol. 2008;158(5):1159-61.
  
  Tijdschrift Psoriasis 2008;29(1):26-27. Dermatoloog Phyllis Spuls: “Goed onderzoek is niet altijd vanzelfsprekend”. Anneke van der Kieft. Nijsten T, Spuls PhI. Adalimumab is a new effective biological and may be better or no worse than MTX in psoriasis. Br J Dermatol 2008;159(1):257-8.
  
  Spuls PhI, Hooft L. Er is geen effectieve therapie voor alopecia areata. Ned Tijdschr Geneeskd. 2008;152:2821. (In het kort)
  
  Brenningmeijer EEA, Sillevis Smitt JH, Spuls PhI, Bos JD. Can patients with intrinsic atopic dermatitis (atopiform dermatitis) have allergen-specific IgE? J Invest Dermatol 2006; …
  
  2007
  
  Opmeer BC, Heydendael VMR, deBorgie CA, Spuls PhI, Bossuyt PMM, Bos JD, deRie MA. Patients with moderate to severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off guestions. J Clin Epidemiol 2007;60:696-703.
  
  Kazlow Stern D, Diamantis S, Smith E, Wei H, Gordon M, Muigai W, Moshier E, Lebwohl, M, Spuls PhI. Water content and other aspects of brittle versus normal fingernails. J Am Acad Dermatol 2007;57:31-6.
  
  2006
  
  De Groot M, Appelman M, Spuls PhI, De Rie MA, Bos JD. Initial experience with routine administration of etanercept in psoriasis. Br J Dermatol 2006, 155:808-14.
  
  2005
  
  Wang K, Spuls PhI. A review of the literature for nail psoriasis. Psoriasis Forum 2005;11:12-14.
  
  2004
  
  Spuls PhI, Witkamp L, Bossuyt PMM, Bos JD. Analyses of the efficacy of treatment with placebo in clinical trials with systemic drugs in psoriasis. Arch of Derm 2004;140:338-344.
  
  Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, de Rie MA. The burden of psoriasis is not determined by disease severity only. J Investig Dermatol Symp Proc 2004;9:131-5.
  
  Opmeer BC, Heydendael VMR, de Borgie CAJM, Spuls PhI, Bossuyt PMM, Bos JD, de Rie MA. Costs of treatment in patients with moderate to severe plaque psoriasis:economic analysis in a randomized controlled comparison of methotrexate and cyclosporine. Arch Dermatol 2004;140:685-690.
  
  Heydendael VMR, Spuls PhI, Opmeer BC, Borgie CAJM de, Reitsma JB, Goldschmidt WFM, Bossuyt PMM, Bos JD, Rie MA de. Methotrexaat en ciclosporine bij de behandeling van psoriasis. Ned Tijdschr Derm Venereol 2004;14:204-5.
  Spuls PI, Bos JD, Rudikoff D. Smallpox: What the dermatologist should know. SKINmed 2004;3:197-208.
  
  Heydendael VMR, Spuls PhI, Bossuyt PMM, Bos JD, deRie MA. Analysis of risk factors in psoriasis patients with methotrexate induced increases in transaminase levels. Arch Dermatol 2004;140:1289-90.
  
  Spuls PI, Tuut MK, van Everdingen JJ, de Rie MA; Werkgroep Psoriasis van de Nederlandse Vereniging voor Dermatologie en Venereologie. Richtlijn foto(chemo)therapie en systemische therapie bij ernstige chronische plaque psoriasis. [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis]. Ned Tijdschr Geneeskd. 2004 Oct 23;148(43):2121-5.
  
  2003
  
  Richtlijn foto(chemo)therapie en systemische therapie bij ernstige chronische plaque psoriasis. Van Zuiden Communications, 2003. ISBN: 90-7690-88-2.
  
  Heydendael VMR, Spuls PhI, Opmeer BC, deBorgie CA, Reitsma JB, Goldschmidt WFM, Bossuyt PMM, Bos JD, deRie MA. Methotrexate versus cyclosporine in moderate to severe chronic plaque psoriasis. N Eng J Med 2003;349:658-65.
  
  Spuls P, Hadi S, Rivera L, Lebwohl M. Retrospective analysis of the treatment of psoriasis of the palms and soles. J Dermatolog Treat 2003;14(Supplement 2):21-25.
  Spuls P, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. J Dermatolog Treat 2003;14(Supplement 2):17-20.
  
  2002
  
  Leent EJM van, Ebelin M-E, Burtin P, Dorobek B, Spuls PhI, Bos JD. Low systemic exposure after repeated topical application of pimecrolimus (Elidel7, SDZ ASM 981) in patients with atopic dermatitis. Dermatology 2002;204:63-8.
  
  Heydendael VMR, Spuls PhI, Berge IJM ten, Bos JD, Rie MA de. Cyclosporin A trough levels: standard practice in dermatology? A systematic review and trough levels measured in psoriasis patients. Br J Dermatol 2002;147:122-129.
  
  2001
  
  Reitamo S, Spuls P, Sassolas B, Lahfa M, Claudy A, Griffiths CE. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol 2001;145(3):438-4.
  
  Heydendael VMR, PhI Spuls, BC Opmeer, CAJM de Borgie, JB Reitsma, WFM Goldschmidt, PMM Bossuyt, JD Bos, MA de Rie. Report for the Development program (College voor Zorgverzekeringen) of the Dutch Government: project 97-009. Methotrexate versus cyclosporine A in moderate to severe chronic plaque psoriasis: a randomized controlled trial. 2001
  
  2000
  
  Spuls PhI, Everdingen JJE van, Bossuyt PMM, Rie MA de Witkamp L, Bos JD. Literatuuronderzoek naar de effectiviteit van patiënten met ernstige chronische psoriasis. Ned Tijdschr Derm Venereol 2000;10:85-8.
  
  Spuls PhI, Kozel MMA, Mekkes JR, Hoekzema R, Baan J, Lieshout JJ van, Brinkhuis M, Wal AC van der. Panniculitis geassocieerd met een kleincellig bronchuscarcinoom. Ned Tijdschr Derm Venereol 2000;10:135-7.
  
  Spuls PhI, Rie MA de. Psoriasis pustulosa van von Zumbusch. Ned Tijdschr Derm Venereol 2000;10:159-161.
  
  Spuls PhI, Witkamp L, Bossuyt PMM, Bos JD. Richtlijnen voor de behandeling van patiënten met ernstige chronische psoriasis. Ned Tijdschr Derm Venereol 2000;10:165-6.
  
  Spuls PhI, Nanninga PB, Mekkes JR. MPO-ANCA geassocieerde vasculitis bij een patiënt met een heterozygote factor V-Leiden. Ned Tijdschr Derm Venereol 2000;10:177-9.
  
  Sillevis Smitt JH, Spuls PhI, Leen EJM van, Vries HJC de, Mulder PGH, Glazenburg EJ, Bos JD. Moet men kinderen met een constitutioneel eczeem continue of in pulse lokaal behandelen met corticosteroïden? Een prospectieve gerandomiseerde dubbel-blinde studie met clobetason butyraat. Ned Tijdschr Derm Venereol 2000;10:204-205.
  
  Spuls PhI, Bos JD. Vitamine D3-derivaten in combinatie met systemische behandeling bij psoriasis. Wegwijzer 2000;4,:1-10.
  
  Spuls PhI, Nanninga PB, Mekkes JR. Met antineutrofiele cytoplasmatische antistoffen tegen myeloperoxidase samenhangende vasculitis bij een patiënt met een heterozygote factor V-Leiden-mutatie. Ned Tijdschr Geneesk 2000;144:2430-1.
  
  Spuls PhI, Brakman M, Folkers E, Winterberg DH, Sillevis Smitt JH. Neonatal lupus erythematosus in 5 children. Eur J Pediat Dermatol 2000;10:155-60.
  
  1999
  
  Zonneveld IM, Spuls PhI, Dekker PJ, Bos JD. Cyclosporin A micro emulsion: dose requirements in patients with psoriasis. Thesis I.M. Zonneveld, Psoriasis, present therapies, maart 1999.
  
  1998
  
  Leent EJM, Gräber M, Thurston M, Wagenaar A, Spuls PhI, Bos JD. Effectiveness of the Ascomycin Macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 1998;134;805-9.
  
  Spuls PhI, Bossuyt PMM, Everdingen JJE, Witkamp L, Bos JD. The development of practice guidelines for the treatment of severe plaque form psoriasis. Arch Dermatol 1998;134:1591-6.
  
  Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PMM. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 1998;134:1532-40.
  
  1997
  
  Spuls PhI, Witkamp L, Bossuyt PMM, Bos JD. A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol 1997;137:943-9.
  
  Spuls PI, Witkamp L, Bossuyt PMM, Bos JD. De ontwikkeling van richtlijnen voor de behandeling van ernstige psoriasis. Tijdschr Soc Geneesk 1997;75:40-1.
  Ruzicka Th, Bieber Th, Schöpf E for the European Tacrolimus Multicenter Atopic Dermatitis Study Group (included Spuls PH). A short-term trial of tacrolimus ointment for atopic dermatitis. N Eng J Med 1997;337:816-21.